Here’s the Argument on Each Side.
Earlier this year, the federal agency that oversees addiction and mental health funding told its grantees they can no longer use federal dollars to buy sterile syringes, pipes, or test strips for fentanyl and other drugs in the supply. For anyone working in or around addiction treatment in Panama City, that decision settled one argument for federal budget purposes and left the underlying disagreement wide open. It’s one of the oldest fights in the field, and both sides have evidence and real losses behind them.
The April Guidance
On April 24, the Substance Abuse and Mental Health Services Administration, known as SAMHSA, sent grantees a letter updating what federal money can pay for. It built on guidance from July 2025, and the agency described the direction as a “clear shift away from harm reduction.” Syringes, pipes, and test strips for fentanyl, xylazine, and medetomidine are now off the list of things federal grants can buy. Naloxone, treatment, and long-term recovery support remain funded. Organizations that hand out test strips can keep doing it with state, local, or private money. They just can’t use federal dollars, so some programs will have to find new funding or shrink.
Case for the Shift
People who support the change start from a simple premise: federal money is limited, and it should go toward treatment, prevention, and long-term recovery. They see supplies like pipes and syringes as helping someone continue using, and they would rather spend the same dollars getting people out of addiction than making it safer to stay in it. According to reporting from STAT, the same agency has also pushed back on treatment that relies on medication alone, and wants medication paired with counseling and recovery support.
The Case Against It
People who oppose the change point to a gap in who gets care. Health policy analysts at Health Affairs have noted that only about 20 to 25 percent of people with opioid use disorder are in treatment at all, and that harm reduction programs are often the first contact someone has with a health worker. A test strip or a clean syringe can keep a person alive, and someone who stays alive can enter treatment later. Critics also expect some harm reduction organizations to close without federal support, which would remove that first point of contact in the communities that have it.
A New Orleans Doctor Got Caught in the Middle
The same disagreement shows up in exam rooms. Earlier this year, KFF Health News followed an addiction medicine doctor in New Orleans who took on the most complicated cases, including people living on the street and long-term patients on high doses of opioids. The doctor used flexible approaches that the American Society of Addiction Medicine supports, such as higher-than-usual medication doses and recovery goals other than abstinence. In 2025, the hospital and the state medical board began scrutinizing that practice, and the reporters described the situation as not black and white.
Boards have a real job to do here, because pill mills exist. A Tennessee medical board president told the reporters that those operations usually leave sparse patient notes that list pain as the complaint. The board’s investigation in Louisiana was still open when the story ran, and no finding had been made.
Where Treatment Centers Sit
A treatment center doesn’t get to sit this one out, and we won’t pretend the two sides are closer than they are. What we can describe is how it plays out day to day. People arrive in very different places. Some are ready to stop everything the day they walk in. Others are still deciding, mostly because they’re afraid of withdrawal. Our MAT program uses Suboxone alongside counseling, because pairing medication with support is a well-established approach for opioid use disorder.
Whatever happens with federal funding, the person across the desk still needs a plan that fits where they are right now. Florida Springs Wellness and Recovery Center is in Panama City, and our residential program for drug and alcohol rehab is one option for people ready for full-time care, whichever side of this debate they would land on.
